Skip to main content

51 publications

Name Date Type Actions

Avis de réunion valant avis de convocation (french)

Mesdames et Messieurs les actionnaires sont convoqués le mardi 30 mai 2017 à 15h30, au siège social, 34, rue du Chêne Sainte-Anne 70200 Lure, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions suivants :

Shareholders´s Meeting

Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2018 (french version)

The registration document of Vetoquinol relative to fiscal year 2018, including the annual financial report relative to fiscal year 2018, was filed with the Autorité des marchés financiers (“the AMF”) on April 29, 2019.

Public releases

Q1 2019 sales: €90.9 million (up 3.7%)

Vetoquinol Group sales for Q1 2019 amounted to €90.9 million, up 2.3% at constant exchange rates and up 3.7% as reportedfrom the same period last year.

Public releases

Vetoquinol finalizes acquisition of Clarion Biociencias in Brazil

Lure (France), April 16, 2019 - Vetoquinol today confirms the completion of its acquisition of Clarion Biociências, a Brazilian veterinary laboratory based in the state of Goiás.

 

Public releases

Formulaire de vote

Shareholders´s Meeting

Avis de réunion valant avis de convocation (french)

Mesdames et Messieurs les actionnaires sont convoqués le mardi 30 mai 2017 à 15h30, au siège social, 34, rue du Chêne Sainte-Anne 70200 Lure, en Assemblée générale mixte, à l’effet de délibérer sur l’ordre du jour et les projets de résolutions suivants :

Shareholders´s Meeting

Vetoquinol signs agreement to acquire Clarion Biociênciasin Brazil

On April 3rd, Vetoquinol signed an agreement to acquire Clarion Biociências, a Brazilian veterinary laboratory based in the state of Goiás.

Public releases

Growth in all financial indicators in 2018. Essentials products sales: €179.4M (up 9.1% at constant exchange rates). Net income group share €36.3M (up 4.0%)

At its meeting on March 19, 2019, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the audited 2018 financial statements.

Public releases

2018 sales: up 3.2% to €367.9 million

9.1% GROWTH IN ESSENTIALS PRODUCTS AT CONSTANT EXCHANGE RATES

 

Public releases

Information relative au code de gouvernance

Lors de la réunion du Conseil d’administration du 16 décembre 2014, les administrateurs ont adopté le code de gouvernance Middlenext. Depuis 2008, Vétoquinol se référait au code AFEP-MEDEF.

Public releases